Advertisement
UK markets close in 4 hours 9 minutes
  • FTSE 100

    8,118.66
    +39.80 (+0.49%)
     
  • FTSE 250

    19,815.71
    +213.73 (+1.09%)
     
  • AIM

    755.56
    +2.44 (+0.32%)
     
  • GBP/EUR

    1.1660
    +0.0003 (+0.03%)
     
  • GBP/USD

    1.2517
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    51,300.76
    +383.45 (+0.75%)
     
  • CMC Crypto 200

    1,383.62
    -12.92 (-0.93%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.11
    +0.54 (+0.65%)
     
  • GOLD FUTURES

    2,359.40
    +16.90 (+0.72%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,058.24
    +140.96 (+0.79%)
     
  • CAC 40

    8,043.04
    +26.39 (+0.33%)
     

Zotefoams' (LON:ZTF) investors will be pleased with their respectable 45% return over the last five years

Zotefoams plc (LON:ZTF) shareholders might be concerned after seeing the share price drop 21% in the last quarter. While that's not great, the returns over five years have been decent. The share price is up 37%, which is better than the market return of 36%.

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

Check out our latest analysis for Zotefoams

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

ADVERTISEMENT

During five years of share price growth, Zotefoams achieved compound earnings per share (EPS) growth of 9.6% per year. The EPS growth is more impressive than the yearly share price gain of 6% over the same period. Therefore, it seems the market has become relatively pessimistic about the company.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

earnings-per-share-growth
earnings-per-share-growth

We know that Zotefoams has improved its bottom line lately, but is it going to grow revenue? If you're interested, you could check this free report showing consensus revenue forecasts.

What About Dividends?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Zotefoams' TSR for the last 5 years was 45%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence!

A Different Perspective

Zotefoams shareholders are down 18% for the year (even including dividends), but the market itself is up 26%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 8% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Even so, be aware that Zotefoams is showing 3 warning signs in our investment analysis , you should know about...

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on GB exchanges.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.